First two commercial patient treatments in Greece
Filed with ASX · · 3 pages · English
Earlier from OncoSil Medical
- OncoSil onboards first patient in PANCOSIL Clinical Trial
- Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer
- Ethics Committee Approves PANCOSIL Clinical Trial
- First patient treatment in Italy
- First patient enrolled in the TRIPP-FFX Clinical Study
Later from OncoSil Medical
- OncoSil receives $1.1m R&D tax incentive
- 84 German hospitals can negotiate fee for Oncosil device
- Placement and Entitlement Offer to raise up to $7.1 million
- Prospectus - Entitlement Offer
- First Austria-based treatments utilising the OncoSil device
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical